Italia markets closed

BMY Jul 2024 42.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,0300-0,0300 (-50,00%)
In data: 12:37PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,0600
Aperto0,0700
Denaro0,0300
Domanda0,0400
Prezzo d'esercizio42,50
Scadenza2024-07-12
Min-Max giorno0,0300 - 0,0700
Contratto - Min-MaxN/D
Volume54
Open Interest307
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri